Monte Rosa Therapeutics Stock Probability of Future Stock Price Finishing Over 44.16
| GLUE Stock | USD 6.94 0.08 1.14% |
Monte |
Monte Rosa Target Price Odds to finish over 44.16
The tendency of Monte Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 44.16 or more in 90 days |
| 6.94 | 90 days | 44.16 | close to zero percent |
Based on a normal probability distribution, the odds of Monte Rosa to move over $ 44.16 or more in 90 days from now is close to zero percent (This Monte Rosa Therapeutics probability density function shows the probability of Monte Stock to fall within a particular range of prices over 90 days) . Probability of Monte Rosa Therapeutics price to stay between its current price of $ 6.94 and $ 44.16 at the end of the 90-day period is about 60.94 .
Given the investment horizon of 90 days Monte Rosa Therapeutics has a beta of -0.32. This usually indicates as returns on the benchmark increase, returns on holding Monte Rosa are expected to decrease at a much lower rate. During a bear market, however, Monte Rosa Therapeutics is likely to outperform the market. Additionally Monte Rosa Therapeutics has an alpha of 0.9728, implying that it can generate a 0.97 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Monte Rosa Price Density |
| Price |
Predictive Modules for Monte Rosa
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Monte Rosa Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Monte Rosa's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Monte Rosa Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Monte Rosa is not an exception. The market had few large corrections towards the Monte Rosa's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Monte Rosa Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Monte Rosa within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.97 | |
β | Beta against Dow Jones | -0.32 | |
σ | Overall volatility | 1.80 | |
Ir | Information ratio | 0.08 |
Monte Rosa Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Monte Rosa for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Monte Rosa Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Monte Rosa is way too risky over 90 days horizon | |
| Monte Rosa appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (135.35 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Monte Rosa Therapeutics currently holds about 294.14 M in cash with (43.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.32. | |
| Monte Rosa has a poor financial position based on the latest SEC disclosures | |
| Over 91.0% of the company shares are owned by institutional investors | |
| Latest headline from zacks.com: Buy 5 Genomics Synthetic Biology Stocks Likely to Soar in Short Term |
Monte Rosa Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Monte Stock often depends not only on the future outlook of the current and potential Monte Rosa's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Monte Rosa's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 51.4 M | |
| Cash And Short Term Investments | 232.4 M |
Monte Rosa Technical Analysis
Monte Rosa's future price can be derived by breaking down and analyzing its technical indicators over time. Monte Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Monte Rosa Therapeutics. In general, you should focus on analyzing Monte Stock price patterns and their correlations with different microeconomic environments and drivers.